The Cochrane Collaboration
Cochrane Reviews
Explore New + Updated Other languages
Full Text:  The Cochrane Library
search & browse | by topic | full list of all reviews | by country of author | by date range

by Topic (Review Group):
Visit the "Haematological Malignancies Group" website here

Browse by topic (Review Group) - For sub-topics (only reviews + protocols), click here

Suggest a topic


View stages (what is this?): all titles Titles protocol Protocols review Reviews

Alemtuzumab for chronic lymphocytic leukaemia (protocol stage)
Alkylating agents for Waldenstrom's macroglobulinaemia
Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia (ALL) in first complete remission (title stage)
Allogeneic peripheral blood stem cell transplantation versus conventional therapy for advanced primary cutaneous T-Cell lymphoma (title stage)
withdrawn
Allogeneic peripheral blood stem cells transplantation versus bone marrow transplantation for the therapy of hematological malignancies (protocol stage)
Alternative thresholds for initiating treatment of Epoetin or Darbepoetin in cancer patients (title stage)
Anti-thymocyte globulins for the prophylaxis and treatment of graft-versus-host disease after allogeneic stem cell / bone marrow transplantation (title stage)
Antibiotics plus colony stimulating factors (CSFs) versus CSFs alone and antibiotics plus CSFs versus no prophylaxis for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation (protocol stage)
Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation (protocol stage)
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia
Antiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignancies (protocol stage)
Arsenic trioxide for the treatment of acute promyelocytic leukaemia (title stage)
Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia (protocol stage)
Bendamustine for patients with lymphoid malignancies (title stage)
Bisphosphonates in multiple myeloma
Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors
Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma (protocol stage)
withdrawn
Chemotherapy alone vs. radiotherapy alone vs. chemotherapy plus radiotherapy in the primary treatment of localised non-Hodgkin's lymphoma (protocol stage)
Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma
Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk
Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (title stage)
withdrawn
Colony stimulating factors for afebrile neutropenia in cancer patients (protocol stage)
Colony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in children with acute lymphoblastic leukaemia
Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma (protocol stage)
New
Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation
Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation
Corticosteroids versus immune globulin for newly diagnosed immune thrombocytopenia (ITP) in childhood (protocol stage)
CXCR4 antagonists for haematopoietic stem cell mobilisation for autologous transplantation in in malignant lymphoma or multiple myeloma patients (title stage)
Cytosine arabinoside for the treatment of acute promyelocytic leukaemia (protocol stage)
Darbepoetin versus rHuErythropoetin for patients with malignant diseases (title stage)
Deferasirox for managing iron overload in patients with myelodysplastic syndrome (protocol stage)
Early versus deferred treatment for early stage multiple myeloma
Erythropoietin or Darbepoetin for patients with cancer
Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data
First-line double high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma (protocol stage)
First-line stem cell transplantation from related donors compared to immunosuppressive treatment for acquired severe aplastic anaemia (protocol stage)
Fludarabine plus intermediate dose cytarabine versus high dose cytarabine for consolidation treatment for acute myeloid leukaemia patients (title stage)
Granulopoiesis-stimulating factors for autologous peripheral stem cell transplantation for lymphoma and multiple myeloma (title stage)
Granulopoiesis-stimulating factors in autologous peripheral stem cell transplantation for haematological malignancy (title stage)
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
Hematopoietic Growth Factors in the Treatment of Acquired Aplastic Anemia (protocol stage)
High-dose chemotherapy followed by autologous stem cell transplantation for the therapy of first relapse of Hodgkin lymphoma (title stage)
High-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient data (protocol stage)
High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults
Hypomethylating Agents or low dosed Ara-C for the Treatment of Patients with Myeolodysplastic Syndrome and Acute Myeloid Leukaemia (title stage)
Imatinib for adult patients with philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) (title stage)
Imatinib for treating patients with Chronic Myelogeneous Leukemia (title stage)
New
Imatinib for treating patients with chronic myelogeneous leukemia (protocol stage)
Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation
New
Interferon-alpha for maintenance of follicular lymphoma
withdrawn
Interventions for early stage Hodgkin's disease in children
Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers (title stage)
Monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia (protocol stage)
Myeloablative high-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults (protocol stage)
Non-myeloablative allogeneic stem cell transplantation versus standard stem cell transplantation for haematological malignancies (title stage)
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival (title stage)
Pegylated liposomal doxorubicin for relapsed or refractory multiple myeloma (title stage)
Physical Exercise for Patients with Hematological Malignancies (title stage)
Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy
Prophylactic platelet transfusion for prevention of haemorrhage after chemotherapy and stem cell transplantation
Purine Antagonists for Chronic Lymphocytic Leukaemia
Radioimmunotherapy for lymphoma (title stage)
Rituximab as maintenance therapy for patients with follicular lymphoma
Rituximab for aggressive Non-Hodgkin Lymphoma (title stage)
Role of thalidomide, and its analogues, as therapy for multiple myeloma (title stage)
Role of Velcade as therapy for multiple myeloma (title stage)
Tacrolimus versus cyclosporine A for prophylaxis of acute graft versus host disease after stem cell transplantation (title stage)
The effect of Erythropoiesis-stimulating Agents for cancer patients regardings Quality of Life: Individual Patient Data Meta-Analysis based on Randomized Controlled Trials (title stage)
The role of allogeneic stem cell transplantation for peripheral T-cell lymphomas (title stage)
New
The role of colony stimulating factors administered for prevention and treatment of infectious complications in patients with acute myelogenous leukemia (protocol stage)
The role of dose intensification with or without autologous stem cell transplantation for peripheral T-cell lymphomas (title stage)
Therapeutic interventions for Burkitt's lymphoma in children
New
TPO receptor agonist for chronic idiopathic thrombocytopenic purpura (protocol stage)
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia (title stage)
Vaccination for Non-Hodgkin Lymphoma (title stage)
Vaccines for prophylaxis of viral infections in patients with hematological malignancies (protocol stage)